Acquisition Details
In October 2025, ENGEL, a leader in injection moulding machines, will acquire Trexel Inc., a Massachusetts-based company known for its MuCell® microcellular foaming technology. This acquisition aims to enhance ENGEL's technological leadership in foaming.
Operational Continuity
Post-acquisition, Trexel will continue to operate independently as Trexel GmbH, headquartered in Austria. The company will maintain its own sales, service, and R&D operations, ensuring continuity for injection moulding customers across various machine brands.
Global Presence
Trexel's existing sites in the USA, Germany, and China will remain unchanged, allowing the company to continue providing sales and service to its global customer base. Levi Kishbaugh will oversee market and customer relations, joined by Johannes Kilian on the management team.
Sustainability and Growth
The acquisition supports ENGEL's strategy to integrate MuCell® technology further into the injection moulding process, facilitating easier scaling and tapping into the growth potential of the foaming market. Foamed products contribute to sustainability by being lighter, requiring less raw material, and reducing the carbon footprint.
